Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Bair

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Investigational New Drugs|May 1, 1991
Effects of isomeric 2-(arylmethylamino)-1,3-propanediols (AMAPs) and clinically established agents on macromolecular synthesis in P388 and MCF-7 cellsC A Carter, K W Bair
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Protein-protein interactions: lessons learnedS K Sharma, T M Ramsey, K W Bair
Investigational New Drugs|April 1, 1992
An efficient multiple-exposure analysis of the toxicity of crisnatol, a DNA intercalator in phase II clinical trialsR M Zucker, D J Adams, K W Bair, et al.
Biochemical Pharmacology|November 6, 1991
Polyploidy induction as a consequence of topoisomerase inhibition. A flow cytometric assessmentR M Zucker, D J Adams, K W Bair, et al.
Molecular Toxicology|October 1, 1989
Limitations of the fluorescent probe viability assayE J Massaro, K H Elstein, R M Zucker, et al.
Anti-Cancer Drug Design|November 10, 1998
Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediolsR T Dorr, W Bellamy, J D Liddil, et al.
Journal of Medicinal Chemistry|September 1, 1990
(1-Pyrenylmethyl)amino alcohols, a new class of antitumor DNA intercalators. Discovery and initial amine side chain structure-activity studiesK W Bair, R L Tuttle, V C Knick, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 29, 1999
Solid-phase total synthesis of polymyxin B1S K Sharma, A D Wu, N Chandramouli, et al.
Cancer Research|June 15, 1990
Evaluation of arylmethylaminopropanediols by a novel in vitro pharmacodynamic assay: correlation with antitumor activity in vivoD J Adams, P J Watkins, V C Knick, et al.
Journal of Medicinal Chemistry|July 1, 1991
2-[(arylmethyl) amino]-2-methyl-1,3-propanediol DNA intercalators. An examination of the effects of aromatic ring variation on antitumor activity and DNA bindingK W Bair, C W Andrews, R L Tuttle, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Investigational New Drugs|May 1, 1991
Effects of isomeric 2-(arylmethylamino)-1,3-propanediols (AMAPs) and clinically established agents on macromolecular synthesis in P388 and MCF-7 cellsC A Carter, K W Bair
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Protein-protein interactions: lessons learnedS K Sharma, T M Ramsey, K W Bair
Investigational New Drugs|April 1, 1992
An efficient multiple-exposure analysis of the toxicity of crisnatol, a DNA intercalator in phase II clinical trialsR M Zucker, D J Adams, K W Bair, et al.
Biochemical Pharmacology|November 6, 1991
Polyploidy induction as a consequence of topoisomerase inhibition. A flow cytometric assessmentR M Zucker, D J Adams, K W Bair, et al.
Molecular Toxicology|October 1, 1989
Limitations of the fluorescent probe viability assayE J Massaro, K H Elstein, R M Zucker, et al.
Anti-Cancer Drug Design|November 10, 1998
Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediolsR T Dorr, W Bellamy, J D Liddil, et al.
Journal of Medicinal Chemistry|September 1, 1990
(1-Pyrenylmethyl)amino alcohols, a new class of antitumor DNA intercalators. Discovery and initial amine side chain structure-activity studiesK W Bair, R L Tuttle, V C Knick, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|July 29, 1999
Solid-phase total synthesis of polymyxin B1S K Sharma, A D Wu, N Chandramouli, et al.
Cancer Research|June 15, 1990
Evaluation of arylmethylaminopropanediols by a novel in vitro pharmacodynamic assay: correlation with antitumor activity in vivoD J Adams, P J Watkins, V C Knick, et al.
Journal of Medicinal Chemistry|July 1, 1991
2-[(arylmethyl) amino]-2-methyl-1,3-propanediol DNA intercalators. An examination of the effects of aromatic ring variation on antitumor activity and DNA bindingK W Bair, C W Andrews, R L Tuttle, et al.
Pageof 2